Healthcare Sales & Marketing Network News: OxyContin

Searching News Database: OxyContin

HSMN NewsFeed - 3 Feb 2017
Intellipharmaceutics Announces FDA Acceptance for Filing of NDA for Rexista(TM) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 25 Nov 2016
Intellipharmaceutics Submits New Drug Application for Rexista(R) (oxycodone hydrochloride extended release), an Abuse Deterrent Opioid Analgesic for the Treatment of Moderate to Severe Pain
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Feb 2016
Collegium Provides Litigation Update
Biopharmaceuticals Litigation

HSMN NewsFeed - 3 Dec 2013
Impax Laboratories Announces OxyContin(R) Patent Challenge Settlement
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 17 Jan 2013
Collegium Pharmaceutical Announces Relocation to Massachusetts
Biopharmaceuticals

HSMN NewsFeed - 17 Dec 2012
Titan Pharmaceuticals Licenses Exclusive Probuphine(R) Commercialization Rights in U.S. and Canada to Braeburn Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing

HSMN NewsFeed - 24 Jul 2012
Relmada Therapeutics Raises $3.0 Million In Initial Closing Of Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 25 Oct 2010
Omeros Receives $20 Million from Vulcan Capital and $5 Million Grant Award from Washington State's Life Sciences Discovery Fund to Advance its GPCR Program
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 2 Sep 2008
Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 2 Sep 2008
Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 2 Apr 2007
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with IMPAX Laboratories
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 2 Apr 2007
IMPAX Settles Oxycontin(R) Litigation; Amends Marketing Agreement with DAVA Pharmaceuticals
Biopharmaceuticals Generics Litigation Licensing

HSMN NewsFeed - 21 Feb 2007
Javelin Pharmaceuticals Names Derek Gallacher as European Managing Director
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Biopharmaceuticals Neurology

HSMN NewsFeed - 18 Oct 2006
TEVA Announces Planned Retirement of President & CEO in 2007
Biopharmaceuticals Personnel

HSMN NewsFeed - 16 Oct 2006
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 16 Oct 2006
Purdue Pharma L.P. Announces Signing of Consent Judgment Ending OxyContin(R) Tablets Patent Lawsuit with Teva Pharmaceuticals
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 12 Oct 2006
Teva Announces Tentative Approval for Generic Risperdal(R) Oral Solution
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 3 Oct 2006
Long-Term Data Demonstrated Significantly Better Patient Adherence to COPAXONE(R) versus Interferons in Multiple Sclerosis Treatment
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Oct 2006
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Sep 2006
Very Active Multiple Sclerosis Patients Benefited from COPAXONE(R) Treatment Following Short-Term Induction with Mitoxantrone
Biopharmaceuticals Neurology

HSMN NewsFeed - 29 Sep 2006
Study Showed Significant and Sustained Efficacy Of COPAXONE(R) Alone Following Short-Term Combination Therapy With IV Steroids in Multiple Sclerosis Patients
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 Sep 2006
New Data Confirmed Antibodies to COPAXONE(R) do not Impact Its Established and Sustained Long-Term Efficacy in Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Sep 2006
Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
Biopharmaceuticals Licensing

HSMN NewsFeed - 29 Aug 2006
Teva Announces Settlement of OxyContin(R) Litigation
Biopharmaceuticals Litigation

HSMN NewsFeed - 29 Aug 2006
Purdue Pharma L.P. Announces Agreement to End OxyContin(R) Patent Lawsuit with Teva Pharmaceuticals
Biopharmaceuticals Litigation

HSMN NewsFeed - 28 Aug 2006
Endo Pharmaceuticals Announces Settlement of OxyContin(R) Patent Case
Biopharmaceuticals Litigation

HSMN NewsFeed - 21 Aug 2006
Teva Announces Health Canada Approves AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 21 Aug 2006
First Patient Enrolled in Study to Evaluate Impact of Regular Neutralizing Antibody (NAb) Testing on Multiple Sclerosis Treatment Patterns
Biopharmaceuticals Neurology

HSMN NewsFeed - 14 Aug 2006
Teva Announces Launch of Generic Zoloft(R)
Biopharmaceuticals Generics

HSMN NewsFeed - 4 Aug 2006
Teva Announces Final Approval of Venlafaxine HCl Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 31 Jul 2006
Teva Neuroscience Announces AZILECT(R) Is Now Available in Pharmacies - the First, Once-Daily Treatment for Parkinson's Disease
Biopharmaceuticals Neurology

HSMN NewsFeed - 27 Jul 2006
Teva Initiates Phase III Study to Confirm Increased Efficacy of Higher Dose of Glatiramer Acetate for the Treatment of Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology

HSMN NewsFeed - 20 Jul 2006
Teva Announces Final Approval of Meloxicam Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 Jul 2006
Teva Announces Tentative Approval of Generic Lotrel(R) Capsules
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Biopharmaceuticals Neurology

HSMN NewsFeed - 30 Jun 2006
Teva Receives FDA Approval for Generic Zoloft(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 27 Jun 2006
Teva Provides Generic Biaxin(R) XL Update
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 23 Jun 2006
Teva Receives First U.S. Approval of Generic Zocor(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 23 Jun 2006
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 23 Jun 2006
Endo Receives FDA Approval for Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate Release Tablets CII
Biopharmaceuticals FDA

HSMN NewsFeed - 22 Jun 2006
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 20 Jun 2006
COPAXONE(R) Reduced Relapses By 75 Percent in Both Treatment-Naive Multiple Sclerosis Patients and Those Failing Betaseron(R)
Biopharmaceuticals Neurology

HSMN NewsFeed - 19 Jun 2006
Teva Receives First FDA Approval for Generic Proscar(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 14 Jun 2006
Teva Announces Tentative Approval of Losartan Potassium & Hydrochlorothiazide Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 31 May 2006
COPAXONE(R) Reduced Relapses and Stabilized Disability as Measured by Expanded Disability Status Scale, When Avonex(R) Failed
Biopharmaceuticals Neurology

HSMN NewsFeed - 28 May 2006
Teva Announces Tentative Approval for Generic Cozaar(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 25 May 2006
Teva Announces Tentative Approval of Simvastatin Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 22 May 2006
Teva Announces Approval of Generic Lexapro(R) Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 8 May 2006
Long-Term Copaxone(R) Study Showed 92% of Multiple Sclerosis Patients Were Still Walking Unaided After a Mean of 10 Years on Treatment
Biopharmaceuticals Neurology

HSMN NewsFeed - 7 May 2006
Teva Announces Approval of Polyethylene Glycol 3350 NF for Oral Solution
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 5 May 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-Based Oxycodone) Commences Pivotal Phase III Program
Biopharmaceuticals

HSMN NewsFeed - 1 May 2006
District Court Grants Teva Summary Judgment for Generic Zocor(R) Exclusivity
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 25 Apr 2006
Teva Receives First FDA Approval for Generic Pravachol(R)
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 21 Apr 2006
Teva Provides Update on Generic Pravachol(R)
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 20 Apr 2006
Teva Announces Stay of Approval for Generic Pravachol Lifted
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 19 Apr 2006
District Court Denies Apotex's Request to Block Teva's Introduction of First Generic Pravachol(R) In The U.S.
Biopharmaceuticals Generics FDA Litigation

HSMN NewsFeed - 12 Apr 2006
Teva Announces Approval of Mitoxantrone Hydrochloride Injection USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 12 Apr 2006
Teva Announces FDA Determination That Generic Pravachol Exclusivity Has Not Been Triggered
Biopharmaceuticals Generics

HSMN NewsFeed - 5 Apr 2006
Teva Announces That Higher Dose of Copaxone(R) Showed Increased Efficacy in Multiple Sclerosis (MS)
Biopharmaceuticals Neurology

HSMN NewsFeed - 2 Apr 2006
Teva Announces Approval of Deferoxamine Mesylate for Injection USP
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 30 Mar 2006
Teva Expands Presence in China
Biopharmaceuticals

HSMN NewsFeed - 16 Mar 2006
Teva Provides Update on Generic Pravachol Exclusivity
Biopharmaceuticals Generics

HSMN NewsFeed - 6 Mar 2006
Teva Announces Tentative Approval of Topiramate Tablets, 50 mg
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 26 Feb 2006
Teva Announces Tentative Approval of Ondansetron Injection USP
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 17 Feb 2006
ORADUR(TM) Technology Milestone: Remoxy(TM) (ORADUR-based oxycodone) Receives Special Protocol Assessment and Commences Pivotal Phase III
Biopharmaceuticals Drug Delivery FDA

HSMN NewsFeed - 16 Feb 2006
Pain Therapeutics and King Pharmaceuticals Receive Special Protocol Assessment for Remoxy(TM) and Commence Pivotal Phase III
Biopharmaceuticals

HSMN NewsFeed - 16 Feb 2006
Teva Announces Tentative Approval of Rabeprazole Sodium Delayed-Release Tablets
Biopharmaceuticals FDA Generics

HSMN NewsFeed - 13 Feb 2006
Teva Announces Tentative Approval of Adenosine Injection
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 9 Feb 2006
Teva Comments on Pfizer Press Release Regarding Azithromycin
Biopharmaceuticals FDA Generics Litigation

HSMN NewsFeed - 1 Feb 2006
Endo Pharmaceuticals Announces Federal Circuit Court of Appeals Remands OxyContin Patent Case
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 31 Jan 2006
FDA Accepts IND for Elite Pharmaceuticals Once-Daily Oxycodone Product
Biopharmaceuticals FDA Drug Delivery

HSMN NewsFeed - 27 Jan 2006
Teva Announces Favorable Court Decision Regarding Generic Allegra
Biopharmaceuticals Generics Litigation

HSMN NewsFeed - 23 Jan 2006
U.S. Federal Trade Commission Clears Teva/IVAX Merger
Biopharmaceuticals Mergers & Acquisitons

HSMN NewsFeed - 12 Jan 2006
Teva Announces Tentative Approval of Divalproex Sodium Delayed-Release Tablets
Biopharmaceuticals Generics FDA

HSMN NewsFeed - 10 Jan 2006
Teva and IVAX Announce that FTC Review Process Continues on Track and Merger Closing is Expected Shortly
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 5 Jan 2006
OxyContin(R) Dismissals and Withdrawals Exceed 400
Biopharmaceuticals Litigation

Return to NewsFeed

Additional items found! 33

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 33 additional stories matching:
OxyContin
(Password required)

FindReps - available on the Apple App Store for iPhone and iPad.